SKI Market

Indian Indices

Sensex

83,450.96 173.81
( 0.21%)

Global Indices

Nasdaq

49,521.93 48.93
(0.10%)

Dow Jones

6,857.17 3.41
(0.05%)

Hang Seng

56,467.09 -339.32
(-0.60%)

Nikkei 225

10,471.28 24.93
(0.24%)

Forex

USD-INR

90.69 0.10
(0.11%)

EUR-INR

107.54 -0.01
(-0.01%)

GBP-INR

123.68 0.19
(0.16%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.9

109518.9

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.18

Back

Cipla consolidated net profit declines 56.97% in the December 2025 quarter

Jan 23,2026

Net profit of Cipla declined 56.97% to Rs 675.80 crore in the quarter ended December 2025 as against Rs 1570.51 crore during the previous quarter ended December 2024. Sales rose 0.02% to Rs 6962.97 crore in the quarter ended December 2025 as against Rs 6961.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	6962.97	6961.60	0
OPM %	18.02	28.57	-
PBDT	1447.37	2195.89	-34
PBT	1169.02	1916.09	-39
NP	675.80	1570.51	-57

83,450.96 173.81 ( 0.21%)

49,521.93 48.93 (0.10%)

6,857.17 3.41 (0.05%)

56,467.09 -339.32 (-0.60%)

10,471.28 24.93 (0.24%)

90.69 0.10 (0.11%)

107.54 -0.01 (-0.01%)

123.68 0.19 (0.16%)

0.59 0.00 (-0.15%)